ESRRA and breast cancer: Our results, demonstrating that decreasing ERRα activity increases glutamine uptake and glutamate excretion in breast cancer cells, are in agreement with the previous reports that ERRα acts as a suppressor in glutamine oxidation, as well as the PPP and OCM pathways [8,38].